tropics-02 data presented at sabcs 2023: implications for the hr breast cancer treatment paradigm
Published 6 months ago • 142 plays • Length 17:31Download video MP4
Download video MP3
Similar videos
-
1:34
sacituzumab govitecan effective for hr metastatic breast cancer regardless of trop-2 status
-
0:32
highlights in her2-low breast cancer at sabcs 2022
-
2:57
key data from the san antonio breast cancer symposium (sabcs) 2022
-
29:57
dr. prudence francis | premenopausal er breast cancer: past, present, future | sabcs 2022
-
4:08
sabcs 2022 highlights
-
22:49
highlights of the 2023 san antonio breast cancer symposium with jason mouabbi, md
-
12:30
dr. ruth o'regan | san antonio breast cancer symposium 2022 | debate on cdk46 inhibitors
-
1:06
sabcs 2022 highlights
-
27:47
dr. melinda telli | sa antonio breast cancer symposium 2022 | clinical research workshop
-
37:59
dr. charles perou | distinguished lectureship in breast cancer research | sabcs 2022
-
2:16
sabcs 2022: destiny-breast02 destiny-breast03
-
1:51:16
dr. bora lim | challenging types of breast cancer | sabcs 2022 | education session
-
16:10
dr. ian krop | san antonio breast cancer symposium 2022 | general session
-
56:30
ask the expert: sabcs highlights
-
2:52
future research directions for breast cancer
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
21:39
new research in metastatic breast cancer | sabcs 2019
-
1:46:57
dr. nicholas turner | what ctdna can tell us | sabcs 2022 | educational session
-
1:58:32
overcoming the big obstacles to find solutions for breast cancer | dr. carlos arteaga | sabcs 2022